BackPredictive Oncology Overview

Predictive Oncology Receivables

Latest receivables for POAI: $6.6M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$6.59M
↑ 10912.15% YoYΔ $6.53M vs prior year quarter

Peer average

Loading

Predictive Oncology Receivables History

Loading

Predictive Oncology vs. peers: Receivables Comparison

Loading

Predictive Oncology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Predictive Oncology (POAI) FAQ

As of the most recent data (March 2026), POAI shows a receivables of $6.6M. That compares with $60K in the prior-year period — up 10912.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, POAI's receivables is now $6.6M (was $60K) — a 10912.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Predictive Oncology is outperforming or lagging.

Tracking POAI's receivables over time shows whether Predictive Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $6.6M That compares with $60K in the prior-year period — up 10912.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Predictive Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $6.6M) with ownership activity and broader fundamentals.

Predictive Oncology's receivables is $6.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.